Analysen von David Adlington
14.09.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
31.08.17 | Gerresheimer overweight | JP Morgan Chase & Co. | |
08.08.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
03.08.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
01.08.17 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
17.07.17 | Gerresheimer overweight | JP Morgan Chase & Co. | |
13.07.17 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
12.06.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
Werbung
|
|||
07.06.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
31.05.17 | Gerresheimer overweight | JP Morgan Chase & Co. | |
10.05.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
04.05.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
23.02.17 | Fresenius overweight | JP Morgan Chase & Co. | |
23.02.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
17.02.17 | Gerresheimer overweight | JP Morgan Chase & Co. | |
16.02.17 | Gerresheimer overweight | JP Morgan Chase & Co. | |
17.01.17 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
12.01.17 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
04.01.17 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
04.01.17 | Gerresheimer overweight | JP Morgan Chase & Co. | |
04.01.17 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
04.01.17 | Fresenius overweight | JP Morgan Chase & Co. | |
14.12.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
29.11.16 | Fresenius overweight | JP Morgan Chase & Co. | |
28.10.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
24.10.16 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
07.10.16 | Gerresheimer overweight | JP Morgan Chase & Co. | |
13.09.16 | Gerresheimer overweight | JP Morgan Chase & Co. | |
02.09.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
03.08.16 | Fresenius overweight | JP Morgan Chase & Co. | |
03.08.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
29.07.16 | Fresenius overweight | JP Morgan Chase & Co. | |
29.07.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
27.07.16 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
08.07.16 | Gerresheimer kaufen | JP Morgan Chase & Co. | |
29.04.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
12.04.16 | Gerresheimer overweight | JP Morgan Chase & Co. | |
08.04.16 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
08.04.16 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
08.04.16 | STADA Neutral | JP Morgan Chase & Co. | |
08.04.16 | Gerresheimer overweight | JP Morgan Chase & Co. | |
08.04.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
08.04.16 | Fresenius overweight | JP Morgan Chase & Co. | |
26.02.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
26.02.16 | Fresenius overweight | JP Morgan Chase & Co. | |
25.02.16 | Fresenius overweight | JP Morgan Chase & Co. | |
25.02.16 | Fresenius Medical Care (FMC) St. overweight | JP Morgan Chase & Co. | |
22.02.16 | EssilorLuxottica Neutral | JP Morgan Chase & Co. | |
17.02.16 | Fresenius overweight | JP Morgan Chase & Co. | |
16.02.16 | Gerresheimer overweight | JP Morgan Chase & Co. |